Cargando…
Functional differences between protamine preparations for the transfection of mRNA
Protamine is a natural cationic peptide mixture used as a drug for the neutralization of heparin and in formulations of slow-release insulin. In addition, Protamine can be used for the stabilization and delivery of nucleic acids (antisense, small interfering RNA (siRNA), immunostimulatory nucleic ac...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470126/ https://www.ncbi.nlm.nih.gov/pubmed/32804028 http://dx.doi.org/10.1080/10717544.2020.1790692 |
_version_ | 1783578524644278272 |
---|---|
author | Jarzebska, Natalia Teresa Lauchli, Severin Iselin, Christoph French, Lars E Johansen, Pal Guenova, Emmanuella Kündig, Thomas M Pascolo, Steve |
author_facet | Jarzebska, Natalia Teresa Lauchli, Severin Iselin, Christoph French, Lars E Johansen, Pal Guenova, Emmanuella Kündig, Thomas M Pascolo, Steve |
author_sort | Jarzebska, Natalia Teresa |
collection | PubMed |
description | Protamine is a natural cationic peptide mixture used as a drug for the neutralization of heparin and in formulations of slow-release insulin. In addition, Protamine can be used for the stabilization and delivery of nucleic acids (antisense, small interfering RNA (siRNA), immunostimulatory nucleic acids, plasmid DNA, or messenger RNA) and is therefore included in several compositions that are in clinical development. Notably, when mixed with RNA, protamine spontaneously generates particles in the size range of 20–1000 nm depending on the formulation conditions (concentration of the reagents, ratio, and presence of salts). These particles are being used for vaccination and immuno-stimulation. Several grades of protamine are available, and we compared them in the context of complex formation with messenger RNA (mRNA). We found that the different available protamine preparations largely vary in their composition and capacity to transfect mRNA. Our data point to the source of protamine as an important parameter for the production of therapeutic protamine-based complexes. |
format | Online Article Text |
id | pubmed-7470126 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-74701262020-09-15 Functional differences between protamine preparations for the transfection of mRNA Jarzebska, Natalia Teresa Lauchli, Severin Iselin, Christoph French, Lars E Johansen, Pal Guenova, Emmanuella Kündig, Thomas M Pascolo, Steve Drug Deliv Research Article Protamine is a natural cationic peptide mixture used as a drug for the neutralization of heparin and in formulations of slow-release insulin. In addition, Protamine can be used for the stabilization and delivery of nucleic acids (antisense, small interfering RNA (siRNA), immunostimulatory nucleic acids, plasmid DNA, or messenger RNA) and is therefore included in several compositions that are in clinical development. Notably, when mixed with RNA, protamine spontaneously generates particles in the size range of 20–1000 nm depending on the formulation conditions (concentration of the reagents, ratio, and presence of salts). These particles are being used for vaccination and immuno-stimulation. Several grades of protamine are available, and we compared them in the context of complex formation with messenger RNA (mRNA). We found that the different available protamine preparations largely vary in their composition and capacity to transfect mRNA. Our data point to the source of protamine as an important parameter for the production of therapeutic protamine-based complexes. Taylor & Francis 2020-08-17 /pmc/articles/PMC7470126/ /pubmed/32804028 http://dx.doi.org/10.1080/10717544.2020.1790692 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Jarzebska, Natalia Teresa Lauchli, Severin Iselin, Christoph French, Lars E Johansen, Pal Guenova, Emmanuella Kündig, Thomas M Pascolo, Steve Functional differences between protamine preparations for the transfection of mRNA |
title | Functional differences between protamine preparations for the transfection of mRNA |
title_full | Functional differences between protamine preparations for the transfection of mRNA |
title_fullStr | Functional differences between protamine preparations for the transfection of mRNA |
title_full_unstemmed | Functional differences between protamine preparations for the transfection of mRNA |
title_short | Functional differences between protamine preparations for the transfection of mRNA |
title_sort | functional differences between protamine preparations for the transfection of mrna |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470126/ https://www.ncbi.nlm.nih.gov/pubmed/32804028 http://dx.doi.org/10.1080/10717544.2020.1790692 |
work_keys_str_mv | AT jarzebskanataliateresa functionaldifferencesbetweenprotaminepreparationsforthetransfectionofmrna AT lauchliseverin functionaldifferencesbetweenprotaminepreparationsforthetransfectionofmrna AT iselinchristoph functionaldifferencesbetweenprotaminepreparationsforthetransfectionofmrna AT frenchlarse functionaldifferencesbetweenprotaminepreparationsforthetransfectionofmrna AT johansenpal functionaldifferencesbetweenprotaminepreparationsforthetransfectionofmrna AT guenovaemmanuella functionaldifferencesbetweenprotaminepreparationsforthetransfectionofmrna AT kundigthomasm functionaldifferencesbetweenprotaminepreparationsforthetransfectionofmrna AT pascolosteve functionaldifferencesbetweenprotaminepreparationsforthetransfectionofmrna |